Redeye gives a short comment on ISAB’s renewed partnership with Karolinska Institutet (KI). Under the partnership, KI will help validate ISAB’s new XposeALI Micro Perfusion tool, including using it to test a Mars dust surrogate for the European Space Agency as part of exploring future manned missions to Mars.

Link to the analysis